ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistance-Reference-Cited by-同舟云学术

ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistance

Published:2017-02 Issue:2 Volume:108 Page:236-242
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Kikuchi Aya¹,Suzuki Tomoyuki¹,Nakazawa Taisuke¹,Iizuka Masateru¹,Nakayama Ayako¹,Ozawa Tohru¹,Kameda Minoru¹,Shindoh Nobuaki¹,Terasaka Tadashi¹,Hirano Masaaki¹,Kuromitsu Sadao¹

Affiliation:

1. Drug Discovery Research; Astellas Pharma Inc.; Tsukuba-shi Ibaraki Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13124/fullpdf

Reference34 articles.

1. Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder;Zhongfa;BMC Med Genomics,2010

2. The present and future burden of urinary bladder cancer in the world;Ploeg;World J Urol,2009

3. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;Maase;J Clin Oncol,2005

4. Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin;Tada;Int J Cancer,2002

5. Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer;Seo;Oncotarget,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies;Cancer Communications;2024-08-19

2. The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma;Cancer Letters;2024-07

3. Insight into the design of FGFR4 selective inhibitors in cancer therapy: Prospects and challenges;European Journal of Medicinal Chemistry;2024-01

4. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention;Journal of Biomolecular Structure and Dynamics;2023-03-30

5. Inhibition of PP2A by LB100 sensitizes bladder cancer cells to chemotherapy by inducing p21 degradation;Cellular Oncology;2022-09-22